Use and Misuse of Opioids in Chronic Pain

Diagnostic and Statistical Manual of Mental Disorders

American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980

Epidemiological features of chronic low-back pain

Andersson, G. B. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01312-4 · Cited by 3,181

Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain

Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., et al. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.10.008 · Cited by 2,192

Neurobiologic advances from the brain disease model of addiction

Volkow, N. D., Koob, G. F., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1511480 · Cited by 2,008

Classification of Chronic Pain—Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms

Harvey, A. M. (1995) · Clinical Journal of Pain · doi:10.1097/00002508-199506000-00024 · Cited by 1,787

The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop

Chou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I., Dana, T., Bougatsos, C., & Deyo, R. A. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2559 · Cited by 1,606

Persistent Pain and Well-being: A World Health Organization Study in Primary Care

Gureje, O., Von Korff, M., Simon, G. E., & Gater, R. (1998) · JAMA · doi:10.1001/jama.280.2.147 · Cited by 1,496

Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies

Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,366

The brain on drugs: from reward to addiction

Volkow, N. D., & Morales, M. (2015) · Cell · doi:10.1016/j.cell.2015.07.046 · Cited by 1,306

A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell

Castro, D. C., & Bruchas, M. R. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.003 · Cited by 306

A Public Health Strategy for the Opioid Crisis

Saloner, B. K., McGinty, E. E., Beletsky, L. A., Bluthenthal, R. N., Beyrer, C., Botticelli, M. P., & Sherman, S. G. (2018) · Public Health Reports · doi:10.1177/0033354918793627 · Cited by 248

The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities

Serafini, R. A., Pryce, K. D., & Zachariou, V. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.10.018 · Cited by 252

Advances in Achieving Opioid Analgesia Without Side Effects

Machelska, H., & Celik, M. Ö. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01388 · Cited by 191

Enhanced Recovery After Surgery (ERAS)

Echeverria-Villalobos, M., Stoicea, N., Todeschini, A. B., Fiorda‐Diaz, J., Uribe, A. A., Weaver, T. E., & Bergese, S. D. (2019) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000792 · Cited by 169

Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases

Plazas, E., Murillo, M. C. Á., Muñoz-Cendales, D. R., & Suárez, L. E. C. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106126 · Cited by 152

Current status of opioid addiction treatment and related preclinical research

Kreek, M. J., Reed, B., & Butelman, E. R. (2019) · Science Advances · doi:10.1126/sciadv.aax9140 · Cited by 111

A bioresorbable peripheral nerve stimulator for electronic pain block

Lee, G., Ray, E., Yoon, H., Genovese, S., Choi, Y. S., Lee, M., Şahin, S., Yan, Y., Ahn, H., Bandodkar, A. J., et al. (2022) · Science Advances · doi:10.1126/sciadv.abp9169 · Cited by 109

An endogenous opioid circuit determines state-dependent reward consumption

Castro, D. C., Oswell, C. S., Zhang, E. T., Pedersen, C. E., Piantadosi, S. C., Rossi, M. A., Hunker, A. C., Guglin, A., Morón, J. A., Zweifel, L. S., et al. (2021) · Nature · doi:10.1038/s41586-021-04013-0 · Cited by 95

Endogenous opioid systems alterations in pain and opioid use disorder

Higginbotham, J. A., Markovic, T., Massaly, N., & Morón, J. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.1014768 · Cited by 94

Genetic pathway analysis reveals a major role for extracellular matrix organization in inflammatory and neuropathic pain

Parisien, M., Samoshkin, A., Tansley, S. N., Piltonen, M. H., Martin, L. J., El-Hachem, N., Dagostino, C., Allegri, M., Mogil, J. S., Khoutorsky, A., et al. (2019) · Pain · doi:10.1097/j.pain.0000000000001471 · Cited by 85

Comorbid chronic pain and opioid use disorder: literature review and potential treatment innovations

Speed, T. J., Parekh, V. K., Coe, W. H., & Antoine, D. G. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1514369 · Cited by 88

CANUE: A Theoretical Model of Pain as an Antecedent for Substance Use

Ferguson, E. G., Zale, E. L., Ditre, J. W., Wesolowicz, D. M., Stennett, B., Robinson, M., & Boissoneault, J. (2020) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaa072 · Cited by 82

Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addiction

Pantazis, C. B., Gonzalez, L. A., Tunstall, B. J., Carmack, S. A., Koob, G. F., & Vendruscolo, L. F. (2021) · Science Advances · doi:10.1126/sciadv.abf0364 · Cited by 74

Resistant and refractory migraine: clinical presentation, pathophysiology, and management

Ornello, R., Andreou, A. P., Matteis, E. D., Jürgens, T. P., Minen, M. T., & Sacco, S. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104943 · Cited by 71

Current strategies toward safer mu opioid receptor drugs for pain management

Ehrlich, A. T., Kieffer, B. L., & Darcq, E. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1586882 · Cited by 69

Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal

Li, A.-L., Lin, X., Dhopeshwarkar, A., Thomaz, A. C., Carey, L. M., Liu, Y., Nikas, S. P., Makriyannis, A., Mackie, K., & Hohmann, A. G. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113233 · Cited by 69

DARK Classics in Chemical Neuroscience: Ibogaine

Wasko, M. J., Witt‐Enderby, P. A., & Surratt, C. K. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00294 · Cited by 65

Concurrent and lagged associations of prescription opioid use with pain and negative affect in the daily lives of chronic pain patients.

Carpenter, R. W., Lane, S. P., Bruehl, S. P., & Trull, T. J. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000402 · Cited by 64

Ameliorative effect of gallic acid in paclitaxel-induced neuropathic pain in mice

Kaur, S., & Muthuraman, A. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.06.001 · Cited by 64

Electrical stimulation for therapeutic approach

Kim, E., Kim, S., Kwon, Y. W., Seo, H., Kim, M., Chung, W. G., Park, W., Song, H., Lee, D. H., Lee, J., et al. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20230003 · Cited by 66

A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic

Cerdá, M., Krawczyk, N., Hamilton, L., Rudolph, K. E., Friedman, S. R., & Keyes, K. M. (2020) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-090419-102727 · Cited by 61

A social affective neuroscience lens on placebo analgesia

Atlas, L. Y. (2021) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2021.07.016 · Cited by 60

Peripherally acting opioid analgesics and peripherally-induced analgesia

Martı́nez, V., & Abalo, R. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000558 · Cited by 55

New Challenges in Addiction Medicine: COVID-19 Infection in Patients With Alcohol and Substance Use Disorders—The Perfect Storm

Spagnolo, P. A., Montemitro, C., & Leggio, L. (2020) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20040417 · Cited by 50

Psychotropic Drugs for the Management of Chronic Pain and Itch

Belinskaia, D. A., Belinskaia, M. A., Barygin, O. I., Vanchakova, N. P., & Shestakova, N. N. (2019) · Pharmaceuticals · doi:10.3390/ph12020099 · Cited by 44

Association of Geography and Access to Health Care Providers With Long‐Term Prescription Opioid Use in Medicare Patients With Severe Osteoarthritis: A Cohort Study

Desai, R. J., Jin, Y., Franklin, P. D., Lee, Y., Bateman, B. T., Lii, J., Solomon, D. H., Katz, J. N., & Kim, S. C. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40834 · Cited by 43

Negative Affect–Related Factors Have the Strongest Association with Prescription Opioid Misuse in a Cross-Sectional Cohort of Patients with Chronic Pain

Gilam, G., Sturgeon, J. A., You, D. S., Wasan, A. D., Darnall, B. D., & Mackey, S. (2019) · Pain Medicine · doi:10.1093/pm/pnz249 · Cited by 43

Overprescribed Medications for US Adults: Four Major Examples

Safer, D. J. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3906 · Cited by 41

Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings

Gordon, A. J., Kenny, M. E., Dungan, M. T., Gustavson, A. M., Kelley, A. T., Jones, A. L., Hawkins, E. J., Frank, J. W., Danner, A. N., Liberto, J. C., et al. (2022) · American Journal on Addictions · doi:10.1111/ajad.13260 · Cited by 40

Variations in mitragynine content in the naturally growing Kratom (Mitragyna speciosa) population of Thailand

Leksungnoen, N., Andriyas, T., Ngernsaengsaruay, C., Uthairatsamee, S., Racharak, P., Sonjaroon, W., Kjelgren, R. K., Pearson, B. J., McCurdy, C. R., & Sharma, A. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.1028547 · Cited by 40

Prevalence of pain flashbacks in posttraumatic stress disorder arising from exposure to multiple traumas or childhood traumatization

Macdonald, B., Salomons, T. V., Meteyard, L., & Whalley, M. G. (2018) · Canadian Journal of Pain · doi:10.1080/24740527.2018.1435994 · Cited by 45

Association of opioid prescription initiation during adolescence and young adulthood with subsequent substance-related morbidity

Quinn, P. D., Fine, K. L., Rickert, M. E., Sujan, A. C., Boersma, K., Chang, Z., Franck, J., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2020) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2020.2539 · Cited by 38

The structural basis for an on–off switch controlling Gβγ-mediated inhibition of TRPM3 channels

Behrendt, M., Gruss, F., Enzeroth, R., Dembla, S., Zhao, S., Crassous, P., Mohr, F., Nys, M., Louros, N. N., Gallardo, R. U., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2001177117 · Cited by 35

Factors mediating pain-related risk for opioid use disorder

Nazarian, A., Negus, S. S., & Martin, T. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108476 · Cited by 35

Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework

Cross, A. J., Buchbinder, R., Mathieson, S., Bourne, A., Maher, C. G., Lin, C. C., & O’Connor, D. A. (2022) · BMJ Quality & Safety · doi:10.1136/bmjqs-2021-014186 · Cited by 38

A cholinergic circuit that relieves pain despite opioid tolerance

Sullere, S., Kunczt, A., & McGehee, D. S. (2023) · Neuron · doi:10.1016/j.neuron.2023.08.017 · Cited by 30

Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu‐opioid receptor

Zhang, J., Song, C., Dai, J., Li, L., Yang, X., & Chen, Z. (2022) · MedComm · doi:10.1002/mco2.148 · Cited by 32

The role of neurologists in tackling the opioid epidemic

Volkow, N. D., & Koroshetz, W. J. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0146-8 · Cited by 29

Bifunctional μ opioid and σ1 receptor ligands as novel analgesics with reduced side effects

Zhuang, T., Xiong, J., Hao, S., Du, W., Liu, Z., Liu, B., Zhang, G., & Chen, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113658 · Cited by 29

An analgesic peptide H-20 attenuates chronic pain via the PD-1 pathway with few adverse effects

Zhao, L., Luo, H., Ma, Y., Zhu, S., Wu, Y., Lu, M., Yao, X., Liu, X., & Chen, G. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204114119 · Cited by 29

Benzylaminofentanyl derivates: Discovery of bifunctional μ opioid and σ1 receptor ligands as novel analgesics with reduced adverse effects

Zhuang, T., Xiong, J., Xia, R., Liang, L., Qi, Z., Zhang, S., Du, W., Chen, Y., Liu, X., & Zhang, G. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114649 · Cited by 27

Intrathecal liproxstatin-1 delivery inhibits ferroptosis and attenuates mechanical and thermal hypersensitivities in rats with complete Freund’s adjuvant-induced inflammatory pain

Deng, Y., Xiang, P., Du, J., Liang, J., & Li, X. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.346547 · Cited by 27

A medial prefrontal cortex-nucleus acumens corticotropin-releasing factor circuitry for neuropathic pain-increased susceptibility to opioid reward

Kai, Y., Li, Y., Sun, T., Yin, W., Mao, Y., Li, J., Xie, W., Chen, S., Wang, L., Li, J., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0152-4 · Cited by 26

Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial

Samet, J. H., Tsui, J. I., Cheng, D. M., Liebschutz, J. M., Lira, M. C., Walley, A. Y., Colasanti, J. A., Forman, L. S., Root, C., Shanahan, C. W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1025 · Cited by 25

The epidemiology of multimorbidity in France: Variations by gender, age and socioeconomic factors, and implications for surveillance and prevention

Coste, J., Valderas, J. M., & Carcaillon‐Bentata, L. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265842 · Cited by 25

Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration

Gordon, A. J., Saxon, A. J., Kertesz, S. G., Wyse, J. J. B., Manhapra, A., Lin, L. A., Chen, W., Hansen, J., Pinnell, D., Huynh, T., et al. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109902 · Cited by 25

Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection

Melo, Z., Ishida, C., Goldaraz-Monraz, M. D. L. P., Rojo, R., & Echavarría, R. (2018) · Non-Coding RNA · doi:10.3390/ncrna4030022 · Cited by 24

A Novel Peptide Interfering with proBDNF-Sortilin Interaction Alleviates Chronic Inflammatory Pain

Ho, I. H. T., Liu, X., Zou, Y., Liu, T., Hu, W., Chan, H., Tian, Y., Zhang, Y., Li, Q., Kou, S., et al. (2019) · Theranostics · doi:10.7150/thno.29703 · Cited by 24

Molecular and Epigenetic Aspects of Opioid Receptors in Drug Addiction and Pain Management in Sport

Mazzeo, F., Meccariello, R., & Guatteo, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097831 · Cited by 25

Continuing War on Pain: A Personalized Approach to the Therapy with Nonsteroidal Anti-Inflammatory Drugs and Opioids

Bach‐Rojecky, L., Vađunec, D., Žunić, K., Kurija, J., Šipicki, S., Gregg, R. A., Mikula, I., & Primorac, D. (2018) · Personalized Medicine · doi:10.2217/pme-2018-0116 · Cited by 23

Novel treatments for chronic pain: moving beyond opioids

O’Brien, J. B., & Roman, D. L. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.008 · Cited by 22

Comparison of the antinociceptive profiles of morphine and oxycodone in two models of inflammatory and osteoarthritic pain in rat

García, M. M., Goicoechea, C., Avellanal, M., Traseira, S., Martin, M., & Sánchez-Robles, E. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.011 · Cited by 22

N-Phenethyl Substitution in 14-Methoxy-N-methylmorphinan-6-ones Turns Selective µ Opioid Receptor Ligands into Dual µ/δ Opioid Receptor Agonists

Dumitrascuta, M., Bermúdez, M., Haddou, T. B., Guerrieri, E., Schläfer, L., Ritsch, A., Hosztafi, S., Lantero, A., Kreutz, C., Massotte, D., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62530-w · Cited by 22

Activation of Neuronal Voltage-Gated Potassium Kv7/KCNQ/M-Current by a Novel Channel Opener SCR2682 for Alleviation of Chronic Pain

Wang, J., Liu, Y., Hu, F., Yang, J., Guo, X., Hou, X., Ju, C., & Wang, K. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000357 · Cited by 21

Traumatic brain injury and the misuse of alcohol, opioids, and cannabis

Jacotte-Simancas, A., Fucich, E. A., Stielper, Z. F., & Molina, P. E. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.003 · Cited by 22

Alcohol-medication interactions: A systematic review and meta-analysis of placebo-controlled trials

Traccis, F., Presciuttini, R., Pani, P. P., Sinclair, J., Leggio, L., & Agabio, R. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.019 · Cited by 23

Analgesic Opioid Ligand Discovery Based on Nonmorphinan Scaffolds Derived from Natural Sources

Smith, M. T., Kong, D., Kuo, A., Imam, M. Z., & Williams, C. M. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01915 · Cited by 21

Opioid-related deaths and previous care for drug use and pain relief in Sweden

Fugelstad, A., Thiblin, I., Johansson, L. A., Ågren, G., & Sidorchuk, A. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.04.022 · Cited by 21

Nanotechnology in Chronic Pain Relief

Chen, J., Jin, T., & Zhang, H. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00682 · Cited by 21

GPR171 Agonist Reduces Chronic Neuropathic and Inflammatory Pain in Male, But Not Female Mice

Ram, A., Edwards, T. M., McCarty, A., Afrose, L., McDermott, M., & Bobeck, E. N. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.695396 · Cited by 19

Chronic inflammatory pain promotes place preference for fentanyl in male rats but does not change fentanyl self-administration in male and female rats

Barattini, A. E., Montanari, C., Edwards, K. N., Edwards, S., Gilpin, N. W., & Pahng, A. R. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109512 · Cited by 18

Study protocol for the targeting effective analgesia in clinics for HIV (TEACH) study – a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIV

Lira, M. C., Tsui, J. I., Liebschutz, J. M., Colasanti, J. A., Root, C., Cheng, D. M., Walley, A. Y., Sullivan, M. M., Shanahan, C. W., O’Connor, K., et al. (2019) · HIV Research & Clinical Practice · doi:10.1080/15284336.2019.1627509 · Cited by 20

Episodic future thinking reduces chronic pain severity: A proof of concept study

Craft, W. H., Tegge, A. N., & Bickel, W. K. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108250 · Cited by 24

Understanding Barriers and Facilitators to the Uptake of Best Practices for the Treatment of Co-Occurring Chronic Pain and Opioid Use Disorder

Varley, A. L., Lappan, S. N., Jackson, J., Goodin, B. R., Cherrington, A., Copes, H., & Hendricks, P. S. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1675920 · Cited by 19

Development of ProTx-II Analogues as Highly Selective Peptide Blockers of Nav1.7 for the Treatment of Pain

Adams, G. L., Pall, P. S., Grauer, S. M., Zhou, X., Ballard, J. E., Vavrek, M., Kraus, R. L., Morissette, P., Li, N., Colarusso, S., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01570 · Cited by 19

DNMT3a in the hippocampal CA1 is crucial in the acquisition of morphine self‐administration in rats

Zhang, J., Jiang, F., Zheng, W., Duan, Y., Jin, S., Shen, F., Liang, J., Li, M., & Sui, N. (2019) · Addiction Biology · doi:10.1111/adb.12730 · Cited by 18

Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis

Wissel, J., Camões-Barbosa, A., Comes, G., Althaus, M., Scheschonka, A., & Simpson, D. M. (2021) · Toxins · doi:10.3390/toxins13120887 · Cited by 18

Activation of MORs in the VTA induces changes on cFos expression in different projecting regions: Effect of inflammatory pain

Campos‐Jurado, Y., Igual-López, M., Padilla, F., Zornoza, T., Granero, L. M., Polache, A., Agustín‐Pavón, C., & Hipólito, L. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104521 · Cited by 18

Mindfulness-Oriented Recovery Enhancement reduces opioid craving, pain, and negative affect among chronic pain patients on long-term opioid therapy: An analysis of within- and between-person state effects

Parisi, A. B., Hanley, A. W., & Garland, E. L. (2022) · Behaviour Research and Therapy · doi:10.1016/j.brat.2022.104066 · Cited by 18

α1‐Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain

Wang, Z., Martellucci, S., Enoo, A. A. V., Austin, D., Gelber, C., & Campana, W. M. (2021) · The FASEB Journal · doi:10.1096/fj.202101031rr · Cited by 17

Substance-Related and Addictive Disorders

(2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890425787.x16_substance_related_disorders · Cited by 25

Inflammation, lipid dysregulation, and transient receptor potential cation channel subfamily V member 4 signaling perpetuate chronic vulvar pain

Bekauri, T., Fischer, S., Honn, K. V., Maddipati, K. R., Love, T., Little, C., Wood, R. W., Bonham, A. D., Linder, M. A., Yule, D. I., et al. (2023) · Pain · doi:10.1097/j.pain.0000000000003088 · Cited by 17

Pain acceptance creates an emotional context that protects against the misuse of prescription opioids: A study in a sample of patients with chronic noncancer pain

Esteve, R., Marcos, E., Reyes-Pérez, Á., López-Martínez, A. E., & Ramírez-Maestre, C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18063054 · Cited by 17

Piloting Smart Home Sensors to Detect Overnight Respiratory and Withdrawal Symptoms in Adults Prescribed Opioids

Wilson, M., Fritz, R., Finlay, M., & Cook, D. J. (2022) · Pain Management Nursing · doi:10.1016/j.pmn.2022.08.011 · Cited by 15

Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons – Effects of Nerve Injury

Stötzner, P., Spahn, V., Celik, M. Ö., Łabuz, D., & Machelska, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01478 · Cited by 17

Synthesis, Biological, and Structural Explorations of New Zwitterionic Derivatives of 14- O -Methyloxymorphone, as Potent μ/δ Opioid Agonists and Peripherally Selective Antinociceptives

Spetea, M., Rief, S. B., Haddou, T. B., Fink, M., Kristeva, E., Mittendorfer, H., Haas, S., Hummer, N., Follia, V., Guerrieri, E., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01327 · Cited by 16

Confronting challenges to opioid risk mitigation in the U.S. health system: Recommendations from a panel of national experts

Finley, E. P., Schneegans, S., Curtis, M. E., Bebarta, V. S., Maddry, J. K., Penney, L., McGeary, D., & Potter, J. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234425 · Cited by 16

Epigenetic Alterations in Prescription Opioid Misuse: New Strategies for Precision Pain Management

Gerra, M. C., Dallabona, C., & Arendt‐Nielsen, L. (2021) · Genes · doi:10.3390/genes12081226 · Cited by 17

Pramipexole treatment attenuates mechanical hypersensitivity in male rats experiencing chronic inflammatory pain

Edwards, S., Callicoatte, C. N., Barattini, A. E., Cucinello‐Ragland, J. A., Melain, A., Edwards, K. N., Gilpin, N. W., Avegno, E. M., & Pahng, A. R. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.108976 · Cited by 16

Incidence and Prevalence of Pain Medication Prescriptions in Pathologies with a Potential for Chronic Pain

Goudman, L., Moens, M., & Pilitsis, J. G. (2023) · Anesthesiology · doi:10.1097/aln.0000000000004863 · Cited by 18

Ulinastatin Exhibits Antinociception in Rat Models of Acute Somatic and Visceral Pain Through Inhibiting the Local and Central Inflammation

Zhan, M.-X., Tang, L., Lu, Y., Wu, H., Guo, Z.-B., Shi, Z.-M., Yang, C.-L., Zou, Y.-Q., Yang, F., & Chen, G. (2021) · Journal of Pain Research · doi:10.2147/jpr.s303595 · Cited by 15

The nexus of opioids, pain, and addiction: Challenges and solutions

Henningfield, J. E., Ashworth, J., Gerlach, K. K., Simone, B., & Schnoll, S. H. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105852 · Cited by 16

Battlefield Acupuncture for Chronic Pain Management in Patients on Long-Term Opioid Therapy

Montgomery, A. D., & Ottenbacher, R. (2019) · Medical Acupuncture · doi:10.1089/acu.2019.1382 · Cited by 15

Embracing Remote Fields as the Fourth Dimension of Tissue Biofabrication

Anand, S., Müller, C., Jensen, B. N., & Chen, M. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202401654 · Cited by 14

The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids

Wilson, M. P., Cucciare, M. A., Porter, A., Chalmers, C. E., Mullinax, S., Mancino, M. J., & Oliveto, A. H. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.05.035 · Cited by 13

Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative

Radmall, A. O., Calder, S. G., Codell, N. K., Kelley, A. T., Hawkins, E. J., Jones, A. L., Hagedorn, H., Reynolds, M. A., & Gordon, A. J. (2022) · Journal of Addictions Nursing · doi:10.1097/jan.0000000000000455 · Cited by 13

Tramadol and Codeine Stacking/Boosting Dose Exposure Induced Neurotoxic Behaviors, Oxidative Stress, Mitochondrial Dysfunction, and Neurotoxic Genes in Adolescent Mice

Ishola, I. O., Eneanya, S. U., Folarin, O. R., Awogbindin, I. O., Abosi, A. J., Olopade, J. O., & Okubadejo, N. U. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00539-x · Cited by 13

The short-term effects of opioid and non-opioid pharmacotherapies on sleep in people with chronic low back pain: A systematic review and meta-analysis of randomized controlled trials.

Puterflam, J., Comis, J., Lan, Q., Liu, C., Lipschitz, A. J., Grunstein, R., Ferreira, P., & Gordon, C. (2022) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2022.101672 · Cited by 11

Impaired alcohol-induced dopamine release in the nucleus accumbens in an inflammatory pain model: behavioral implications in male rats

Campos‐Jurado, Y., Lorente, J. D., González-Romero, J. L., Granero, L. M., Polache, A., & Hipólito, L. (2020) · Pain · doi:10.1097/j.pain.0000000000001915 · Cited by 13

Pain-driven emergency department visits and food insecurity: a cross-sectional study linking Canadian survey and health administrative data

Men, F. K., Urquia, M. L., & Tarasuk, V. S. (2022) · CMAJ Open · doi:10.9778/cmajo.20210056 · Cited by 12

Traumatic Brain Injury and Opioids: Twin Plagues of the Twenty-First Century

Jammoul, M., Jammoul, D., Wang, K., Kobeissy, F. H., & DePalma, R. G. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2023.05.013 · Cited by 12

Neuropeptide and cytokine regulation of pain in the context of substance use disorders

Delery, E., & Edwards, S. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108153 · Cited by 12

From pain patient to junkie: An economic theory of painkiller consumption and its impact on wellbeing and longevity

Strulik, H. (2021) · Journal of Health Economics · doi:10.1016/j.jhealeco.2021.102432 · Cited by 13

Everybody Hurts: Intersecting and Colliding Epidemics and the Need for Integrated Behavioral Treatment of Chronic Pain and Substance Use

Witkiewitz, K. A., & Vowles, K. E. (2023) · Current Directions in Psychological Science · doi:10.1177/09637214231162366 · Cited by 13

Hyperbaric Oxygen Therapy for Pain, Opioid Withdrawal, and Related Symptoms: A Pilot Randomized Controlled Trial

Wilson, M., Bindler, R. J., Stanek, K., Layton, M. E., & Quock, R. M. (2022) · Pain Management Nursing · doi:10.1016/j.pmn.2022.03.001 · Cited by 11

Opioid Agents and Cardiac Arrhythmia: A Literature Review

Golibkhon, A., Bazarbaev, A., & Ugli, M. M. F. (2023) · Cureus · doi:10.7759/cureus.38007 · Cited by 13

The allosteric inhibition of glycine transporter 2 by bioactive lipid analgesics is controlled by penetration into a deep lipid cavity

Wilson, K. A., Mostyn, S. N., Frangos, Z. J., Shimmon, S., Rawling, T., Vandenberg, R. J., & O’Mara, M. L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100282 · Cited by 11

Associations of opioid prescription dose and discontinuation with risk of substance-related morbidity in long-term opioid therapy

Quinn, P. D., Chang, Z., Bair, M. J., Rickert, M. E., Gibbons, R. D., Kroenke, K., & D'Onofrio, B. M. (2021) · Pain · doi:10.1097/j.pain.0000000000002415 · Cited by 11

Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics

Desgagné, M., Chartier, M., Lagard, C., Ferková, S., Choquette, M., Longpré, J., Côté, J., Boudreault, P., & Sarret, P. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202405941 · Cited by 10

Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy

Sehgal, N., Colson, J., & Smith, H. S. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.846517 · Cited by 79

The Economic Impact of Opioid Use in the Management of Chronic Nonmalignant Pain

Lipman, A. G., & Webster, L. R. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.10.891 · Cited by 26

Chronic Non-cancer Pain Management and Addiction: A Review

Genova, A., Dix, O., Thakur, M., & Sangha, P. S. (2020) · Cureus · doi:10.7759/cureus.6963 · Cited by 27

Use of Opioids in Management of Chronic Noncancer Pain

Kornfeld, H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00023 · Cited by 1

New Department of Veterans Affairs and Department of Defense Guidelines on Pain Management With Opioids: Comment and Concern

McLellan, A. T. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0814 · Cited by 4